KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Goodwill: 2020-2024

Historic Goodwill for AbCellera Biologics (ABCL) over the last 5 years, with Dec 2024 value amounting to $47.8 million.

  • AbCellera Biologics' Goodwill changed negligibly% to $47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.8 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $47.8 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of FY2024, AbCellera Biologics' Goodwill stood at $47.8 million, which was down 0.00% from $47.8 million recorded in FY2023.
  • In the past 5 years, AbCellera Biologics' Goodwill registered a high of $47.8 million during FY2021, and its lowest value of $31.5 million during FY2020.
  • In the last 3 years, AbCellera Biologics' Goodwill had a median value of $47.8 million in 2024 and averaged $47.8 million.
  • Data for AbCellera Biologics' Goodwill shows a peak YoY soared of 51.77% (in 2021) over the last 5 years.
  • Over the past 5 years, AbCellera Biologics' Goodwill (Yearly) stood at $31.5 million in 2020, then soared by 51.77% to $47.8 million in 2021, then remained steady at $47.8 million in 2022, then remained steady at $47.8 million in 2023, then remained steady at $47.8 million in 2024.